alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis

BACKGROUND: Alemtuzumab is a humanised monoclonal antibody that alters the circulating lymphocyte pool, causing prolonged lymphopenia, thus remoulding the immune repertoire that accompanies homeostatic lymphocyte reconstitution. It has been proved more effective than interferon (IFN) 1a for the trea...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cochrane Database Syst Rev
Main Authors: Zhang, Jian, Shi, Shengliang, Zhang, Yueling, Luo, Jiefeng, Xiao, Yousheng, Meng, Lian, Yang, Xiaobo
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Ltd 2017
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6486233/
https://ncbi.nlm.nih.gov/pubmed/29178444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010968.pub2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker